製品の概要

  • 製品名Riluzole (PK 26124)
  • 製品の詳細
    Neuroprotective agent. Modulates glutamate transmission.
  • 別名
    • PK 26124
  • 生理活性の詳細Neuroprotective agent with anticonvulsant, sedative, anxiolytic, anti-ischemic and anesthetic properties. Inhibits glutamate release, enhances glutamate uptake, blocks voltage-dependent Na+ channels, antagonises NMDA receptors and inhibits GABA uptake. Reported to offer neuroprotection and some therapeutic potential for amyotrophic lateral sclerosis and Huntingdon's disease.
  • 精製度> 99%

製品の特性

    Riluzole (PK 26124) (ab120272) 使用論文

    This product has been referenced in:
    • Fumagalli E  et al. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol 578:171-6 (2008). Read more (PubMed: 18036519) »
    • Lamanauskas N & Nistri A Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro. Eur J Neurosci 27:2501-14 (2008). Read more (PubMed: 18445055) »
    • Doble A The pharmacology and mechanism of action of riluzole. Neurology 47:S233-41 (1996). Read more (PubMed: 8959995) »

    See 1 Publication for this product

    Product Wall

    There are currently no Abreviews or Questions for ab120272.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"